David Risinger Stock Analyst Profile - Leerink Partners Research Coverage - Stocknear

David Risinger

Stock Analyst at Leerink Partners

(5)
# 206
Out of 5,493 analysts
202
Total ratings
Success rate
Average return

38 Stocks

Name Action PT Current % Upside Ratings Updated
VRTX Vertex Pharmaceutica...
Upgrades: Outperform
458 456
385.74 18.21% 5 Sep 25, 2025
MTSR Metsera
Downgrades: Market Perform
77 57
52.25 9.09% 2 Sep 24, 2025
ROIV Roivant Sciences
Maintains: Outperform
18 22
15.17 45.02% 5 Sep 18, 2025
JNJ Johnson & Johnson
Downgrades: Market Perform
169 153
179.71 -14.86% 4 May 13, 2025
REGN Regeneron Pharmaceut...
Upgrades: Outperform
762 834
563.9 47.9% 9 Feb 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
206
220.68 -6.65% 7 Nov 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
55 73
44.1 65.53% 4 Nov 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
49 69
15.2 353.95% 2 Nov 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
16
7.26 120.39% 1 Oct 24, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
44
n/a n/a 2 Sep 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
106 153
33.98 350.26% 2 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 10
14.07 -28.93% 3 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
28 2
2.09 -4.31% 2 Jul 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
47
23.58 99.32% 1 Apr 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Outperform
267 318
272.98 16.49% 4 Oct 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 11
23.26 -52.71% 2 Aug 15, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
410 458
724.6 -36.79% 16 May 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
42
73.75 -43.05% 3 Mar 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
81 91
112.1 -18.82% 3 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
49 48
23.76 102.02% 14 Feb 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
88 117
n/a n/a 12 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
7 10
n/a n/a 2 Jun 24, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
35 37
10.22 262.04% 2 Feb 22, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
162 176
127 38.58% 3 Apr 1, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
18 16
9.52 68.07% 1 Mar 10, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
53 45
21.45 109.79% 7 Mar 5, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
5 7
n/a n/a 8 Mar 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
22 35
6.47 440.96% 4 Feb 26, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
31 41
19.6 109.18% 5 Nov 24, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
167 174
143.52 21.24% 9 Nov 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Equal-Weight
51
35.04 45.55% 1 Jul 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underweight
13 8
18.34 -56.38% 14 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
23 18
n/a n/a 12 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
97 89
78.54 13.32% 8 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
20 16
27.89 -42.63% 6 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
5 3
9.75 -69.23% 4 Apr 2, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Equal-Weight
156
n/a n/a 8 Jan 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Equal-Weight
14 35
n/a n/a 5 Aug 17, 2018